IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ampfield Management, L.P. | 44,543 | $431,000 | 0.35% |
| MANGROVE PARTNERS IM, LLC | 200,000 | $1,934,000 | 0.20% |
| SPRING CREEK CAPITAL LLC | 400,000 | $3,868,000 | 0.19% |
| Vestcor Inc | 400,000 | $3,868,000 | 0.13% |
| KNOTT DAVID M | 36,000 | $348,000 | 0.12% |
| Radcliffe Capital Management, L.P. | 300,000 | $2,901,000 | 0.09% |
| Hudson Bay Capital Management LP | 621,750 | $6,012,000 | 0.07% |
| BERKLEY W R CORP | 68,776 | $666,000 | 0.07% |
| PICTON MAHONEY ASSET MANAGEMENT | 200,000 | $1,934,000 | 0.06% |
| Polar Asset Management Partners Inc. | 500,000 | $4,835,000 | 0.05% |